Question to the Home Office:

To ask the Secretary of State for the Home Department, with reference to the Government response to the Advisory Council on the Misuse of Drugs' report, Barriers to Research Part 2: Schedule 1 Controlled Drugs, published on 16 July 2025, what progress her Department has made on (a) establishing the proposed pilot scheme to exempt universities and hospitals from the requirement to obtain a Home Office licence for research involving Schedule 1 controlled drugs, (b) creating an exemption for clinical studies with MHRA, HRA and Research Ethics Committee approval, (c) reviewing the domestic and import/export licensing system, and (d) developing the framework to assess the impact of those policy changes.

The Government responded to ACMD recommendations on reducing barriers to clinical research with Schedule 1 drugs in July 2025. A cross-government officials group is in place and is developing the policy and has engaged with other departments, agencies, stakeholders and international partners. The Government remains committed to implementing the recommendations and will publish further plans in due course.